We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Stuart Rich

Stuart Rich MD

Professor of Medicine, University of Chicago, Chicago, Illinois

Dr. Stuart Rich is Professor of Medicine at the University of Chicago, and a faculty member of the Center for Pulmonary Hypertension within the Section of Cardiology. Dr. Rich is one of the world’s most recognized experts on pulmonary hypertension. For more than three decades he has dedicated his research and clinical efforts to finding better solutions for pulmonary heart disease. Dr. Rich has a career interest in understanding the causes and treatments of pulmonary hypertension. He was principle investigator for the NIH Registry on Primary Pulmonary Hypertension, the first of its kind, and has been the leader of the largest clinical center in the USA for evaluating and treating patients with pulmonary hypertension since 1980. Dr. Rich has conducted pioneering research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease. This knowledge has lead to the discovery of more effective treatments for pulmonary hypertension, including the use of medicines like anticoagulants, calcium channel blockers, and prostacyclins. His pioneering research has led to a greater understanding of all types of pulmonary hypertension.

Dr. Rich is an elected Fellow of many medical societies, including The American College of Physicians, The American College of Cardiology, The American Heart Association, and The American College of Chest Physicians.

Dr. Rich has been listed among the country’s best doctors by Castle Connolly Ltd. He has published hundreds of clinical articles and book chapters on pulmonary heart disease, and has been a leader in dozens of clinical research trials. In addition, he is currently the Chairman of the Board of the Pulmonary Vascular Research Institute, an organization that is committed to bringing advances in treating pulmonary vascular diseases to the developing world, and Chairman of the steering committee of the Pulmonary Hypertension International Academic Research Consortium.